Add Company
Join Now

EnClear Therapies Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

N/A

Total Funding

Medical Equip

Industry

Estimated Revenue & Valuation

  • EnClear Therapies's estimated annual revenue is currently $3.3M per year.(i)
  • EnClear Therapies's estimated revenue per employee is $251,000

Employee Data

  • EnClear Therapies has 13 Employees.(i)
  • EnClear Therapies grew their employee count by -24% last year.

EnClear Therapies's People

NameTitleEmail/Phone
1
Head EngineeringReveal Email/Phone
2
President & CEO, Co-FounderReveal Email/Phone
3
Regulatory LeadReveal Email/Phone
4
Mechanical EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.8M393%N/AN/A
#2
$8.5M343%N/AN/A
#3
$3M12-29%N/AN/A
#4
$5630M7477-11%$450MN/A
#5
$4.5M186%N/AN/A
#6
$7.2M5727%$29.6MN/A
#7
$14.3M57-12%N/AN/A
#8
$2.3M186%$44MN/A
#9
$40.7M162-1%N/AN/A
#10
$45.7M182-5%N/AN/A
Add Company

What Is EnClear Therapies?

At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop solutions that improve and extend the lives of patients with CNS disease. The team at EnClear is developing systems and medical interventions that Access, Recirculate & Modify CSF for: › Targeted removal of toxicity from CSF correlated to neurodegenerative disease progression. › Continuous localized delivery of therapeutics & monitoring of CSF to ensure effective and personalized therapy.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$3.3M

Revenue (est)

-24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EnClear Therapies News

2022-04-06 - BioWorld MedTech Patent Highlights: Week 13

Assignee: Alessa Therapeutics Inc; University of California. Inventors: Desai, Pujan; Hall, Keith; Maroney, ... Assignee: EnClear Therapies.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M140%N/A
#2
$2.4M16-52%N/A
#3
$1.4M16-6%N/A
#4
$1M170%N/A
#5
$2.9M18-36%N/A